| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2015 | Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers | Hsieh M.-H.; Tsai C.-H.; Lin C.-C.; TSAI-KUN LI ; Hung T.-W.; Chang L.-T.; Hsin L.-W.; Teng S.-C. | Cellular and Molecular Life Sciences | 5 | 6 | |
| 2013 | Topoisomerase II-mediated DNA cleavage and mutagenesis activated by nitric oxide underlie the inflammation-associated tumorigenesis | Yang Y.-C.; Chou H.-Y.E.; Shen T.-L.; Chang W.-J.; Tai P.-H.; TSAI-KUN LI | Antioxidants and Redox Signaling | 18 | 18 | |
| 2017 | Trichodermin induces c-Jun N-terminal kinase-dependent apoptosis caused by mitotic arrest and DNA damage in human p53-mutated pancreatic cancer cells and xenografts | Chien M.-H.; Lee T.-H.; Lee W.-J.; Yeh Y.-H.; TSAI-KUN LI ; Wang P.-C.; Chen J.-J.; Chow J.-M.; Lin Y.-W.; Hsiao M.; Wang S.-W.; Hua K.-T. | Cancer Letters | 10 | 10 | |
| 2001 | Tumor cell death induced by topoisomerase-targeting drugs | TSAI-KUN LI ; Liu L.F. | Annual review of Pharmacology and Toxicology | 465 | 438 | |
| 2000 | Ubiquitin, SUMO-1, and UCRP in camptothesin sensitivity and resistance | Desai S.D.; Yong M.A.O.; Sun M.E.I.; TSAI-KUN LI ; Jiaxi W.U.; Liu L.F.; New Jersey | Annals of the New York Academy of Sciences | 24 | 21 | |
| 2001 | Ubiquitin/26s proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells | Desai S.D.; TSAI-KUN LI ; Rodriguez-Bauman A.; Liu L.F.; Rubin E.H. | Cancer Research | 182 | ||
| 2008 | WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: Identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers | Hsiao C.-J.; TSAI-KUN LI ; Chan Y.-L.; Hsin L.-W.; Liao C.-H.; Lee C.-H.; Lyu P.-C.; Guh J.-H. | Biochemical Pharmacology | 34 | 31 |
